Literature DB >> 2917192

Characterization of the serum In(Lu)-related antigen: identification of a serum protein related to erythrocyte p80.

M G Lucas1, A M Green, M J Telen.   

Abstract

The In(Lu) gene has been shown previously to downregulate expression by erythrocytes and by a subset of leukocytes of an 80-Kd protein antigen defined by monoclonal antibody (MoAb) A3D8. A3D8 antibody has also been shown by inhibition studies to recognize a serum antigen; this serum antigen is present in reduced amount in serum from In(Lu) donors. The present study demonstrates that the serum antigen recognized by A3D8 antibody also resides on a protein similar in size to the protein present in erythrocyte membranes. Studies using chromatographically purified protein have further shown that this antigen shares many epitopes with that present in RBCs and is therefore likely to be extremely homologous or identical to the erythrocyte In(Lu)-related p80.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917192

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

2.  Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules.

Authors:  H Yang; R M Binns
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

3.  Glycoprotein CD44 expression and its association with survival in breast cancer.

Authors:  H Joensuu; P J Klemi; S Toikkanen; S Jalkanen
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

4.  Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.

Authors:  G J Dougherty; P M Landorp; D L Cooper; R K Humphries
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

5.  Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.

Authors:  D Masson; M G Denis; M Denis; D Blanchard; M J Loirat; E Cassagnau; P Lustenberger
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

Review 6.  Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.

Authors:  Yunyuan Zhang; Chunming Ding; Jing Wang; Guirong Sun; Yongxian Cao; Longqiang Xu; Lan Zhou; Xian Chen
Journal:  J Orthop Surg Res       Date:  2015-12-23       Impact factor: 2.359

Review 7.  Diagnostic accuracy of CD44V6 for osteosarcoma: a meta-analysis.

Authors:  Yunyuan Zhang; Limin Lun; Baozhi Zhu; Qing Wang; Chunming Ding; Yanlin Hu; Weili Huang; Lan Zhou; Xian Chen; Hai Huang
Journal:  J Orthop Surg Res       Date:  2016-11-03       Impact factor: 2.359

8.  Role of CD44 as a marker of cancer stem cells in head and neck cancer.

Authors:  Serena Trapasso; Eugenia Allegra
Journal:  Biologics       Date:  2012-11-01

9.  Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.

Authors:  M Salmi; K Grön-Virta; P Sointu; R Grenman; H Kalimo; S Jalkanen
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

10.  Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.

Authors:  J Lesley; Q He; K Miyake; A Hamann; R Hyman; P W Kincade
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.